Toggle Offcanvas
...
 
Tofacitinib Tenders

Tofacitinib Tenders

View Tofacitinib tenders, RFPs and contracts. Bid on readily available Tofacitinib tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Tofacitinib tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Tofacitinib.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Tofacitinib market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Tofacitinib tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

13 Live Notices for Tofacitinib Tenders

Showing 1 to 13

Medicinal Product With The Active Ingredient Tofacitinib Citrate
country Czech Republic
posting date21 Jan 2025
deadline18 Feb 2025
Open House Original Discount Agreements 2024-12 - Tofacitinib
country Germany
posting date18 Nov 2024
deadline31 Dec 2026
Open House Original Discount Agreements 2024-12 - Tofacitinib
country Germany
posting date18 Nov 2024
deadline31 Dec 2026
Open House Contracts For Multiple Active Ingredients/Active Ingredient Combinations
country Germany
posting date14 Jun 2024
deadline01 Jun 2026
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tofacitinib
country Germany
posting date03 Oct 2023
deadline10 Sep 2025
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Substance Tofacitinib, Atc L04Aa29 For The Period 09/01/2023 - 08/31/2025
country Germany
posting date21 Jul 2023
deadline05 Jul 2025
Completion Of A Non-Excl. Discount Agreement According To § 130C Paragraph 1 Sgb V For Tofacitinib, Atc Code: L04Aa29 For The Period From July 1St, 2023 To June 30Th, 2025
country Germany
posting date24 May 2023
deadline05 May 2025
Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Tofacitinib (L04Aa29) As Part Of A So-Called Open House Model.
country Germany
posting date18 Mar 2023
deadline28 Feb 2025
Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Tofacitinib (L04Aa29) As Part Of A So-Called Open House Model.
country Germany
posting date18 Mar 2023
deadline28 Feb 2025
Tab/Cap Tofacitinib 11 Mg Specn: Tab/Cap Tofacitinib 11 Mg
country India
posting date10 Feb 2025
deadline13 Feb 2025
(Ph.No.25155) Tofacitinib 5 Mg Tab/Cap.
country India
posting date04 Feb 2025
deadline21 Feb 2025
Tablet Tofacitinib 5 Mg
country India
posting date01 Feb 2025
deadline14 Mar 2025
(Ami No.8.110) (2025-26) (Tab/Cap) Tofacitinib 5 Mg
country India
posting date31 Jan 2025
deadline14 Feb 2025

Share Share this page